For those of us working on size liberation, the FDA’s 2021 approval of semaglutides like Ozempic for weight loss has certainly thrown a wrench into the works. Arriving during a moment in which ideas ranging from body positivity and neutrality, to fat liberation were abuzz in the public discourse, the new glp-1s quickly derailed the conversation.

Read more